Breaking News

JHP Pharma in CTM Pact

April 17, 2013

Will provide clinical supplies for late-phase trials

JHP Pharmaceuticals has entered into an agreement with an undisclosed biotechnology company to provide clinical supplies for late-phase trials. JHP will manufacture the product at its Rochester, MI facility, which provides clinical batch production to commercialization and offers services including regulatory, analytical methods development, package engineering, stability testing and validation.
 
Stuart Hinchen, JHP’s chief executive officer, said, “Our record of cGMP compliance, driven by experienced Quality and Regulatory Teams, continues to be one of the key reasons customers choose JHP. Additionally, both new and established customers recognize our approach to ongoing investment in people and facilities. Our use of disposable product contact equipment is another leading factor in the selection process. JHP’s strategic use of disposables provides our customers with manufacturing process efficiencies that result in reduced cycle time.”

Related Contract Manufacturing:

Related Compliance:

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • A Case for One Assay Analysis of PK and Immunogenicity in Biosimilar Research

    A Case for One Assay Analysis of PK and Immunogenicity in Biosimilar Research

    Stephanie Mowery, Sherri Rinker, Franklin Spriggs and Bo Kowalcyk , AIT Bioscience||June 2, 2015
    Moving forward clinical studies will have to include a comparative assessment of pharmacokinetics and immunogenicity to the original reference biologic drug

  • Growth Prospects for Pharmaceutical Contract Packaging

    Growth Prospects for Pharmaceutical Contract Packaging

    Walt Berghahn , Healthcare Compliance Packaging Council (HCPC)||June 2, 2015
    Spurred by several trends including the patent cliff, new product launches and changes in healthcare, the contract packaging market is looking at sustained growth in the years ahead